The Peptide Network Regulated by Angiotensin Converting Enzyme (ACE) in Hematopoiesis

Overview

Journal Cell Cycle

Specialty Cell Biology

Date 2011 Mar 29

PMID 21441775

Citations 16

Authors

Xiao Z Shen

Kenneth E Bernstein

Affiliations

Soon will be listed here.

Abstract

The concept of a local bone marrow renin-angiotensin system (RAS) has been introduced and accumulating evidence suggests that the local RAS is actively involved in hematopoiesis. Angiotensin converting enzyme (ACE) is a key player in the RAS and makes the final effector angiotensin II. Besides angiotensin II, ACE also regulates a panel of bioactive peptides, such as substance P, Ac-SDKP and angiotensin 1-7. These peptides have also been individually reported in the regulation of pathways of hematopoiesis. In this setting, an ACE-regulated peptide network orchestrating hematopoiesis has emerged. Here, we focus on this peptide network and discuss the roles of ACE and its peptides in aspects of hematopoiesis. Special attention is given to the recent revelation that ACE is a bona fide marker of hematopoietic stem cells.

Citing Articles

Cancer Stem Cells and the Renin-Angiotensin System in the Tumor Microenvironment of Melanoma: Implications on Current Therapies.

Kilmister E, Tan S Int J Mol Sci. 2025; 26(3).

PMID: 39941158 PMC: 11818896. DOI: 10.3390/ijms26031389.

Screening for urinary markers predicting hematopoietic stem cell injury induced by busulfan using genetically diverse mice.

Sun Y, Guan B, Liu X, Zhang L, Wang X, Meng A Animal Model Exp Med. 2023; 6(2):146-154.

PMID: 37062934 PMC: 10158946. DOI: 10.1002/ame2.12320.

Reversal of aging-associated increase in myelopoiesis and expression of alarmins by angiotensin-(1-7).

Chittimalli K, Jahan J, Sakamuri A, Weyrick H, Winkle W, Adkins S Sci Rep. 2023; 13(1):2543.

PMID: 36782016 PMC: 9925828. DOI: 10.1038/s41598-023-29853-w.

Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide.

Turk S, Turk C, Akbar M, Kucukkaraduman B, Isbilen M, Demirkol Canli S PLoS One. 2020; 15(11):e0242497.

PMID: 33237942 PMC: 7688131. DOI: 10.1371/journal.pone.0242497.

Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers.

Medjebar S, Truntzer C, Perrichet A, Limagne E, Fumet J, Richard C Oncoimmunology. 2020; 9(1):1836766.

PMID: 33178495 PMC: 7595630. DOI: 10.1080/2162402X.2020.1836766.

References

Fernandez-Duenas V, Ciruela F, Gandia J, Sanchez S, Planas E, Poveda R . Histamine H3 receptor activation potentiates peripheral opioid-mediated antinociception: substance P role in peripheral inflammation in mice. Eur J Pharmacol. 2010; 638(1-3):72-7. DOI: 10.1016/j.ejphar.2010.04.022. View

Tavian M, Biasch K, Sinka L, Vallet J, Peault B . Embryonic origin of human hematopoiesis. Int J Dev Biol. 2010; 54(6-7):1061-5. DOI: 10.1387/ijdb.103097mt. View

Rameshwar P, Gascon P, Ganea D . Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins. J Immunol. 1993; 151(5):2484-96. View

Rodgers K, Xiong S, Steer R, diZerega G . Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells. 2000; 18(4):287-94. DOI: 10.1634/stemcells.18-4-287. View

Coutton C, GUIGON M, Bohbot A, Ferrani K, Oberling F . Photoprotection of normal human hematopoietic progenitors by the tetrapeptide N-AcSDKP. Exp Hematol. 1994; 22(11):1076-80. View

Rieger K, Papet M, Wdzieczak-Bakala J, Morgat J, Thierry J, Voelter W . Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline. Biochem J. 1993; 296 ( Pt 2):373-8. PMC: 1137706. DOI: 10.1042/bj2960373. View

Savary K, Michaud A, Favier J, Larger E, Corvol P, Gasc J . Role of the renin-angiotensin system in primitive erythropoiesis in the chick embryo. Blood. 2004; 105(1):103-10. DOI: 10.1182/blood-2004-04-1570. View

Azizi M, Rousseau A, Ezan E, Guyene T, Michelet S, Grognet J . Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest. 1996; 97(3):839-44. PMC: 507123. DOI: 10.1172/JCI118484. View

Jokubaitis V, Sinka L, Driessen R, Whitty G, Haylock D, Bertoncello I . Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Blood. 2007; 111(8):4055-63. DOI: 10.1182/blood-2007-05-091710. View

10.

Zhuo J, Carretero O, Peng H, Li X, Regoli D, Neugebauer W . Characterization and localization of Ac-SDKP receptor binding sites using 125I-labeled Hpp-Aca-SDKP in rat cardiac fibroblasts. Am J Physiol Heart Circ Physiol. 2006; 292(2):H984-93. PMC: 2276842. DOI: 10.1152/ajpheart.00776.2006. View

11.

Huang W, Wang Q . Bone marrow endothelial cells secrete thymosin beta4 and AcSDKP. Exp Hematol. 2001; 29(1):12-8. DOI: 10.1016/s0301-472x(00)00634-2. View

12.

Sirinek L, ODorisio M . Modulation of immune function by intestinal neuropeptides. Acta Oncol. 1991; 30(4):509-17. DOI: 10.3109/02841869109092410. View

13.

Tsubakimoto Y, Yamada H, Yokoi H, Kishida S, Takata H, Kawahito H . Bone marrow angiotensin AT1 receptor regulates differentiation of monocyte lineage progenitors from hematopoietic stem cells. Arterioscler Thromb Vasc Biol. 2009; 29(10):1529-36. DOI: 10.1161/ATVBAHA.109.187732. View

14.

Sosne G, Qiu P, Goldstein A, Wheater M . Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB J. 2010; 24(7):2144-51. DOI: 10.1096/fj.09-142307. View

15.

Watanabe T, Brown G, Kelsey L, Yan Y, Jackson J, Ewel C . In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation. Exp Hematol. 1996; 24(6):713-21. View

16.

Harmer D, Gilbert M, Borman R, Clark K . Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002; 532(1-2):107-10. DOI: 10.1016/s0014-5793(02)03640-2. View

17.

Grassin-Delyle S, Buenestado A, Vallat L, Naline E, Marx S, Decocq J . Expression and proliferative effect of hemokinin-1 in human B-cells. Peptides. 2011; 32(5):1027-34. DOI: 10.1016/j.peptides.2011.02.012. View

18.

Yamada K, Iyer S, Chappell M, Ganten D, Ferrario C . Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension. 1998; 32(3):496-502. DOI: 10.1161/01.hyp.32.3.496. View

19.

Riviere G . [Angiotensin-converting enzyme: a protein conserved during evolution]. J Soc Biol. 2010; 203(4):281-93. DOI: 10.1051/jbio/2009032. View

20.

Di Daniel E, Glover C, Grot E, Chan M, Sanderson T, White J . Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity. Mol Cell Neurosci. 2009; 41(3):373-82. DOI: 10.1016/j.mcn.2009.03.003. View